Research activity includes projects investigating stellate cell function in hepatic fibrosis; the impact of obesity on chronic liver disease; the effect of inflammation on esophageal motility; and esophageal impedance in Barrett’s syndrome. The Division also is participating in pharmaceutical trials in hepatitis C virus (HCV) therapy and inflammatory bowel disease. Other research initiatives include the study of biomarkers in gastric cancer; mechanisms of achlorhydria in Heliobacter pylori (HP) infection and endoscopic development; as well as projects related to nutrition such as total parenteral nutrition associated liver disease. | 
